ADXN Competitors & Alternatives
Compare Addex Therapeutics Ltd with similar stocks in the same industry
Biotechnology
ADXN
Main Stock$4.06
-23.25%
Tradestie Score
33
Market Cap
$8.71M
Revenue Growth
-72.7%
Analyst Upside
+638.9%
Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)
Bottleneck Score: 2/10
Drug Discovery Biotech
Drug Design
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CLYM
Climb Bio, Inc. Common Stock
|
$10.36
-4.69%
|
$133.50M | - | 41 | Compare |
|
SRZN
Surrozen, Inc. Common
|
$31.61
-0.19%
|
$117.07M | - | 33 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$29.54
-3.53%
|
$110.20M | - | 35 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$3.11
-3.42%
|
$84.52M | - | 47 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$7.84
-2.85%
|
$67.94M | - | 48 | Compare |
|
BCDA
BioCardia, Inc. Common Stock
|
$0.83
+0.61%
|
$14.11M | - | 52 | Compare |
|
KZIA
Kazia Therapeutics Limited American Depositary Shares
|
$6.62
-4.75%
|
$11.44M | - | 36 | Compare |
|
DRMA
Dermata Therapeutics, Inc. Common Stock
|
$0.62
-6.01%
|
$3.50M | - | 41 | Compare |
|
AFIB
AFIB
|
- | - | - | - | Compare |
|
NMAD
NMAD
|
$2.35
-36.49%
|
- | - | 39 | Compare |
More ADXN Analysis
Data updated: Nov 15, 2026 | Industry: Biotechnology (SIC 2834)
221 stocks in this industry